Follow
Ed Day
Ed Day
Clinical Reader
Verified email at bham.ac.uk
Title
Cited by
Cited by
Year
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation
M Connock, A Juarez-Garcia, S Jowett, E Frew, Z Liu, RJ Taylor, ...
NIHR Health Technology Assessment programme: Executive Summaries, 2007
6172007
BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
AR Lingford-Hughes, S Welch, L Peters, DJ Nutt
Journal of Psychopharmacology 26 (7), 899-952, 2012
2752012
Drug Misuse and Dependence: Guidelines on Clinical Management
DHE the devolved administrations
Department of Health (England), the Scottish Government, Welsh Assembly …, 2007
205*2007
Thiamine for Wernicke‐Korsakoff Syndrome in people at risk from alcohol abuse
E Day, P Bentham, R Callaghan, T Kuruvilla, S George
Cochrane Database of Systematic Reviews, 2004
1852004
Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol
E Day, PW Bentham, R Callaghan, T Kuruvilla, S George
Cochrane Database of Systematic Reviews, 2013
1602013
Breaking the habit: a retrospective analysis of desistance factors among formerly problematic heroin users
DW Best, S Ghufran, E Day, Rajashree, J Loaring
Drug and alcohol review 27 (6), 619-624, 2008
1382008
Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
Y Adi, A Juarez-Garcia, D Wang, S Jowett, E Frew, E Day, S Bayliss, ...
Health Technology Assessment (Winchester, England) 11 (6), iii-iv, 1, 2007
992007
Can we prevent drug related deaths by training opioid users to recognise and manage overdoses?
RL Gaston, D Best, V Manning, E Day
Harm Reduction Journal 6 (1), 1-8, 2009
922009
Implementing and evaluating social behaviour and network therapy in drug treatment practice in the UK: a feasibility study
A Copello, E Williamson, J Orford, E Day
Addictive Behaviors 31 (5), 802-810, 2006
852006
Mobile phone ownership, usage and readiness to use by patients in drug treatment
J Milward, E Day, E Wadsworth, J Strang, M Lynskey
Drug and alcohol dependence 146, 111-115, 2015
842015
A comparison of stress levels, coping styles and psychological morbidity between graduate-entry and traditional undergraduate medical students during the first 2 years at a UK …
R Zvauya, F Oyebode, EJ Day, CP Thomas, LA Jones
BMC research notes 10 (1), 1-10, 2017
722017
Outpatient versus inpatient opioid detoxification: a randomized controlled trial
E Day, J Strang
Journal of Substance Abuse Treatment 40 (1), 56-66, 2011
712011
Alcohol use disorders and the heart
E Day, JHF Rudd
Addiction 114 (9), 1670-1678, 2019
682019
First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation
G Georgiou, K Webb, K Griggs, A Copello, J Neuberger, E Day
Liver Transplantation 9 (7), 772-775, 2003
622003
Alcohol and substance abuse in solid-organ transplant recipients
R Parker, MJ Armstrong, C Corbett, EJ Day, JM Neuberger
Transplantation 96 (12), 1015-1024, 2013
612013
Inpatient versus other settings for detoxification for opioid dependence
E Day, J Ison, J Strang
Cochrane Database of Systematic Reviews, 2005
592005
The hierarchy of needs and care planning in addiction services: What Maslow can tell us about addressing competing priorities?
D Best, E Day, T McCarthy, I Darlington, K Pinchbeck
Addiction Research & Theory 16 (4), 305-307, 2008
572008
United Kingdom substance misuse treatment workers' attitudes toward 12-step self-help groups
E Day, RL Gaston, E Furlong, V Murali, A Copello
Journal of Substance Abuse Treatment 29 (4), 321-327, 2005
562005
Relationship between drug treatment engagement and criminal thinking style among drug-using offenders
D Best, E Day, A Campbell, PM Flynn, DD Simpson
European Addiction Research 15 (2), 71-77, 2009
512009
Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety …
J Strang, R McDonald, B Tas, E Day
Addiction 111 (4), 574-582, 2016
482016
The system can't perform the operation now. Try again later.
Articles 1–20